More than 1.3 million pounds ($1.68 million) has been raised to help 11-month-old Charlie Gard travel to America for treatment.
But little has changed for baby Charlie, who suffers from a rare genetic disease that has left him brain damaged and unable to breathe unaided.
The life support he is receiving at a London hospital soon will be turned off over the objections of his parents, who want to take him to the United States for experimental therapy they believe could prolong his life.
The European Court of Human Rights last week rejected an appeal from Charlie's parents, Chris Gard and Connie Yates, exhausting their legal options.
They have been spending time with Charlie before he is taken off life support.
By wading into the case in recent days, President Donald Trump and Pope Francis have given Gard and Yates new hope and shined an international spotlight on an ethical debate that pits the rights of parents to decide what's best for their children against the authorities with responsibility for ensuring that people who can't speak for themselves receive the most appropriate care.
Great Ormond Street Hospital said today there were no new updates in Charlie's care.
Trump tweeted Monday that he would be "delighted" to help Charlie, who is suffering from mitochondrial depletion syndrome, which causes progressive muscle weakness.
The president's comment came after Pope Francis issued a statement saying the parents' rights to treat their son "until the end" should be respected.
The Vatican children's hospital studied whether it was possible for Great Ormond Street to transfer Charlie to Rome. But Bambino Gesu hospital President Mariella Enoc said she was informed that the board of the London hospital said Charlie cannot be moved for legal reasons.
"I was contacted by the mother, who is a very determined and decisive person and doesn't want to be stopped by anything," Enoc told reporters. "She asked us to try to verify the possibility that this treatment is done. And our doctors and scientists are looking into the possibility."
The fight over keeping Charlie alive is not about money. Charlie's parents have used a crowdfunding website to raise the money needed to pay for his treatment in the U.S. Instead, it revolves around an ethical debate about what's best for the child.
The rights of the child take primacy, rather than the rights of parents to make the call. It is a principle that applies even in cases where parents have an alternative point of view, according to Britain's Court of Appeal.
And Britain's courts have been consistent in this case. Three courts agreed that the experimental treatment would be futile and may "well cause pain, suffering and distress to Charlie." The parents then took their case to the European Court of Human Rights, which refused to intervene and endorsed the British judges' decision.
"It's this terrible, terrible situation," she said. "It's a horrible thing to have to decide."
In the United States, such disputes are normally negotiated between parents and doctors, according to Arthur Caplan, head of the division of bioethics at New York University Langone Medical Center in New York City.
A family's ability to afford endless care usually poses a bigger obstacle than ethical disagreements.
After an outcry from conservatives, Pope Francis issued a statement of his own, insisting on the need to respect the wishes of the parents to "accompany and treat" their son to the very end.
Caplan said Charlie's situation is a reminder that medicine and technology can't fix everything, even in wealthy countries with cutting-edge technology.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
